Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain.
This report contains market size and forecasts of Lewy Body Dementia Treatment in Global, including the following market information:
Global Lewy Body Dementia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lewy Body Dementia Treatment market was valued at 4386.4 million in 2021 and is projected to reach US$ 5463.6 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Modafinil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lewy Body Dementia Treatment include Novartis, Pfizer, Bayer, GlaxoSmithKline, Mylan, Sanofi, Johnson & Johnson, Teva Pharmaceuticals and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lewy Body Dementia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lewy Body Dementia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lewy Body Dementia Treatment Market Segment Percentages, by Type, 2021 (%)
Modafinil
Benzodiazepine
Antidepressants
Cholinesterase Inhibitors
Antipsychotic Drugs
Carbidopa-Levodopa
Global Lewy Body Dementia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lewy Body Dementia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Lewy Body Dementia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lewy Body Dementia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lewy Body Dementia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lewy Body Dementia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Bayer
GlaxoSmithKline
Mylan
Sanofi
Johnson & Johnson
Teva Pharmaceuticals
Eli Lilly
Eisai
Takeda Pharmaceutical
Allergan
Bausch Health Companies
BioArctic
Sumitomo Dainippon Pharma
Jazz Pharmaceuticals
Hisamitsu Pharmaceutical